Stay updated on Cabotegravir vs TDF/FTC in Women Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir vs TDF/FTC in Women Clinical Trial page.

Latest updates to the Cabotegravir vs TDF/FTC in Women Clinical Trial page
- Check3 days agoChange DetectedThe page shows a new revision tag: v3.6.3 replacing the previous v3.6.2, signaling a minor update to the page build. This update does not modify the study content or reported results.SummaryDifference0.0%

- Check10 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, representing a minor version update. This change does not modify any study content, eligibility criteria, or user-facing information.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe recruitment status was updated to No longer looking for participants, new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was standardized with a revision note updated to v3.6.0.SummaryDifference0.3%

- Check32 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a minor maintenance update to the page.SummaryDifference0.0%

- Check53 days agoChange DetectedVersion v3.5.4 replaces v3.5.3. This appears to be a routine site update rather than a modification to study content.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page's revision now lists v3.5.3 as the current revision, replacing the previous v3.5.2, indicating an update to the page's revision history.SummaryDifference0.0%

Stay in the know with updates to Cabotegravir vs TDF/FTC in Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir vs TDF/FTC in Women Clinical Trial page.